Position in JNJ
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$4,131,076
+$212,948 QoQ
Shares Held
16,266
+1.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#1,751
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 73%
Shared 27%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Belpointe Asset Management LLC holds $43,294,431 across 10 Drug Manufacturers - General names. JNJ ranks #4 (9.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
46,672 | $11,744,542 | |
| 2 | LLY |
ELI LILLY & Co
|
7,399 | $8,874,583 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
125,071 | $7,206,591 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
16,266 | $4,131,076 | |
| 5 | MRK |
Merck & Co., Inc.
|
30,259 | $3,888,281 | |
| 6 | PFE |
Pfizer Inc
|
156,552 | $3,769,772 | |
| 7 | AMGN |
Amgen Inc
|
6,723 | $2,434,532 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
6,464 | $816,661 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,131,076 | 16,266 | Shares | Other | 2026-07-31 | |
| 2026-03-31 | $3,918,128 | 16,029 | Shares | Other | 2026-04-28 | |
| 2025-12-31 | $3,103,422 | 14,996 | Shares | Other | 2026-01-27 | |
| 2025-09-30 | $3,666,309 | 19,773 | Shares | Other | 2025-11-03 | |
| 2025-06-30 | $2,322,869 | 15,207 | Shares | Other | 2025-07-22 | |
| 2025-03-31 | $5,338,223 | 32,189 | Shares | Other | 2025-05-20 | |
| 2024-12-31 | $3,429,229 | 23,712 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $3,815,216 | 23,542 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $3,420,728 | 23,404 | Shares | Other | 2024-08-02 | |
| 2024-03-31 | $3,147,190 | 19,895 | Shares | Other | 2024-05-08 | |
| 2023-12-31 | $3,494,988 | 22,298 | Shares | Other | 2024-02-13 | |
| 2023-09-30 | $4,896,001 | 31,435 | Shares | Other | 2023-11-15 | |
| 2023-06-30 | $7,010,268 | 42,353 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $13,246,455 | 85,461 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $13,989,266 | 79,192 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $10,326,148 | 63,211 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,308,000 | 46,803 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $5,687,487 | 32,091 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $4,806,382 | 28,096 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $4,564,797 | 28,265 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,274,673 | 25,948 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $4,319,939 | 26,285 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $3,482,504 | 22,128 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,663,936 | 24,610 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,542,188 | 25,188 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $2,243,240 | 17,107 | Shares | Sole | 2020-07-20 | |
| No filing history on record for this holder in this stock. | ||||||